Key Points
- Director Mark Hancock sold 144,318 PACS Group shares at an average price of $44.57, generating approximately $6.43 million. The sale was made under a pre-arranged Rule 10b5-1 plan and reduced his ownership by just 0.27%.
- PACS Group reported quarterly results above expectations, with EPS of $0.63 versus the $0.54 consensus estimate and revenue of $1.43 billion versus $1.41 billion expected.
- Analyst sentiment remains broadly positive: five analysts rate the stock Buy and two rate it Hold, producing a “Moderate Buy” consensus and an average price target of $58.80, despite recent insider selling.
PACS Group, Inc. (NYSE:PACS - Get Free Report) Director Mark Hancock sold 144,318 shares of the stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $44.57, for a total transaction of $6,432,253.26. Following the completion of the sale, the director directly owned 53,674,566 shares in the company, valued at $2,392,275,406.62. This trade represents a 0.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Hancock also recently made the following trade(s):
- On Tuesday, September 15th, Mark Hancock sold 155,682 shares of PACS Group stock. The stock was sold at an average price of $42.47, for a total transaction of $6,611,814.54.
- On Thursday, July 9th, Mark Hancock sold 4,966 shares of PACS Group stock. The shares were sold at an average price of $45.06, for a total value of $223,767.96.
- On Wednesday, July 8th, Mark Hancock sold 20,338 shares of PACS Group stock. The shares were sold at an average price of $45.07, for a total value of $916,633.66.
- On Monday, July 6th, Mark Hancock sold 142,163 shares of PACS Group stock. The shares were sold at an average price of $45.33, for a total value of $6,444,248.79.
- On Thursday, July 2nd, Mark Hancock sold 12,825 shares of PACS Group stock. The stock was sold at an average price of $45.01, for a total value of $577,253.25.
- On Wednesday, July 1st, Mark Hancock sold 6,080 shares of PACS Group stock. The stock was sold at an average price of $45.02, for a total value of $273,721.60.
- On Friday, June 26th, Mark Hancock sold 61,931 shares of PACS Group stock. The shares were sold at an average price of $40.50, for a total value of $2,508,205.50.
- On Thursday, June 25th, Mark Hancock sold 138,069 shares of PACS Group stock. The shares were sold at an average price of $40.33, for a total value of $5,568,322.77.
- On Wednesday, June 17th, Mark Hancock sold 63,680 shares of PACS Group stock. The shares were sold at an average price of $35.31, for a total value of $2,248,540.80.
PACS Group Stock Performance
PACS stock opened at $42.01 on Wednesday. The firm has a market cap of $6.65 billion, a price-to-earnings ratio of 24.42, a PEG ratio of 1.39 and a beta of -0.13. PACS Group, Inc. has a twelve month low of $10.31 and a twelve month high of $49.49. The business's fifty day simple moving average is $44.71 and its two-hundred day simple moving average is $39.13. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21.
PACS Group (NYSE:PACS - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.09. The company had revenue of $1.43 billion during the quarter, compared to analysts' expectations of $1.41 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. Analysts predict that PACS Group, Inc. will post 2.13 earnings per share for the current year.
Hedge Funds Weigh In On PACS Group
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Dimensional Fund Advisors LP grew its stake in PACS Group by 370.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company's stock worth $25,051,000 after buying an additional 614,250 shares during the last quarter. 8 Knots Management LLC purchased a new stake in PACS Group in the fourth quarter valued at about $23,421,000. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in PACS Group in the first quarter valued at about $6,762,000. Bank of New York Mellon Corp acquired a new stake in PACS Group in the second quarter worth about $8,196,000. Finally, Principal Financial Group Inc. acquired a new stake in PACS Group in the first quarter worth about $3,171,000.
Analyst Upgrades and Downgrades
PACS has been the topic of several research analyst reports. Zacks Research cut PACS Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, September 9th. UBS Group lifted their target price on PACS Group from $57.00 to $60.00 and gave the company a "buy" rating in a research report on Thursday, August 6th. JPMorgan Chase & Co. upped their target price on PACS Group from $47.00 to $58.00 and gave the stock an "overweight" rating in a report on Friday, September 4th. Oppenheimer increased their price target on PACS Group from $48.00 to $57.00 and gave the stock an "outperform" rating in a research report on Monday, August 10th. Finally, Weiss Ratings lowered PACS Group from a "hold (c+)" rating to a "hold (c)" rating in a research note on Wednesday, August 5th. Five research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $58.80.
Check Out Our Latest Research Report on PACS
Key Headlines Impacting PACS Group
Here are the key news stories impacting PACS Group this week:
- Positive Sentiment: Wall Street remains constructive on PACS Group. Truist Financial, Oppenheimer, UBS, and JPMorgan have assigned price targets ranging from $57 to $62, while the reported consensus target is $58.80 versus recent trading levels. Analysts cite the company’s growth outlook and maintain an overall “Moderate Buy” rating. PACS Group insider trading and analyst coverage
- Positive Sentiment: The company’s latest quarterly results exceeded expectations, with earnings per share of $0.63 versus the $0.54 consensus estimate and revenue of $1.43 billion versus $1.41 billion expected. This supports the case for continued earnings growth in PACS Group’s skilled-nursing and post-acute-care operations.
- Neutral Sentiment: PACS Group presented at the 2026 Jefferies Healthcare Services and Technology Conference on September 15. Management discussed operations and its growth strategy, but the announcement did not disclose new financial guidance or a material business update. PACS Group Jefferies conference announcement
- Negative Sentiment: Director Mark Hancock sold 300,000 shares across September 14–15 for roughly $13.0 million, while CEO Jason Murray sold more than 10,000 shares in the latest reported transactions. The sales add near-term supply and may concern investors, although Hancock and Murray still retain more than 53 million and 54 million shares, respectively; the reported sales represent only small reductions in their holdings. PACS Group director insider sale filing
PACS Group Company Profile
(
Get Free Report)
PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.
The company's broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
